Cargando…
Cryptotanshinone Protects against PCOS-Induced Damage of Ovarian Tissue via Regulating Oxidative Stress, Mitochondrial Membrane Potential, Inflammation, and Apoptosis via Regulating Ferroptosis
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of childbearing age. Cryptotanshinone (CRY) has been shown to be effective in reversing reproductive disorders, but whether it can be used in the treatment of polycystic ovary syndrome remains unclear. We aimed to explor...
Autores principales: | Liu, Honglin, Xie, Jiani, Fan, Limin, Xia, Yue, Peng, Xia, Zhou, Jianhua, Ni, Xiaorong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9001078/ https://www.ncbi.nlm.nih.gov/pubmed/35419170 http://dx.doi.org/10.1155/2022/8011850 |
Ejemplares similares
-
Retracted: Cryptotanshinone Protects against PCOS-Induced Damage of Ovarian Tissue via Regulating Oxidative Stress, Mitochondrial Membrane Potential, Inflammation, and Apoptosis via Regulating Ferroptosis
por: Longevity, Oxidative Medicine and Cellular
Publicado: (2023) -
Cryptotanshinone Reverses Reproductive and Metabolic Disturbances in PCOS Model Rats via Regulating the Expression of CYP17 and AR
por: Yu, Jin, et al.
Publicado: (2014) -
Cryptotanshinone induces apoptosis of activated hepatic stellate cells via modulating endoplasmic reticulum stress
por: Hou, Xiao-Xue, et al.
Publicado: (2023) -
Cryptotanshinone protects skin cells from ultraviolet radiation-induced photoaging via its antioxidant effect and by reducing mitochondrial dysfunction and inhibiting apoptosis
por: Guo, Keke, et al.
Publicado: (2022) -
Cryptotanshinone alleviates polycystic ovary syndrome in rats by regulating the HMGB1/TLR4/NF-κB signaling pathway
por: Yang, Yijiao, et al.
Publicado: (2020)